Klaus Martin

Company: Topas Therapeutics

Job title: Chief Executive Officer

Seminars:

A nanoparticle platform for multiple immune tolerance therapies 3:00 pm

Broad therapeutic potential of our proprietary Topas Particle Conjugates delivering peptide antigens to special liver cells Diverse mechanism-of-action through different immune pathways to rebalance the immune system Pemphigus vulgaris and Celiac disease as strong clinical modelsRead more

day: Day One